ArticleInternational journal of molecular sciences2023

Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial-Mesenchymal Transition and Stemness Properties.

Feng-Che Kuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.